- Home
- UTMD vs CRDF Comparison
UTMD vs CRDF Comparison
Compare UTMD & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTMD
- CRDF
- Stock Information
- Founded
- UTMD 1978
- CRDF 1999
- Country
- UTMD United States
- CRDF United States
- Employees
- UTMD N/A
- CRDF N/A
- Industry
- UTMD Medical/Dental Instruments
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UTMD Health Care
- CRDF Health Care
- Exchange
- UTMD Nasdaq
- CRDF Nasdaq
- Market Cap
- UTMD 171.3M
- CRDF 196.2M
- IPO Year
- UTMD N/A
- CRDF N/A
- Fundamental
- Price
- UTMD $53.60
- CRDF $2.66
- Analyst Decision
- UTMD
- CRDF Strong Buy
- Analyst Count
- UTMD 0
- CRDF 4
- Target Price
- UTMD N/A
- CRDF $12.25
- AVG Volume (30 Days)
- UTMD 15.6K
- CRDF 1.1M
- Earning Date
- UTMD 04-29-2025
- CRDF 05-08-2025
- Dividend Yield
- UTMD 2.27%
- CRDF N/A
- EPS Growth
- UTMD N/A
- CRDF N/A
- EPS
- UTMD 3.78
- CRDF N/A
- Revenue
- UTMD $39,273,000.00
- CRDF $587,000.00
- Revenue This Year
- UTMD N/A
- CRDF N/A
- Revenue Next Year
- UTMD N/A
- CRDF N/A
- P/E Ratio
- UTMD $14.24
- CRDF N/A
- Revenue Growth
- UTMD N/A
- CRDF N/A
- 52 Week Low
- UTMD $51.26
- CRDF $2.01
- 52 Week High
- UTMD $77.33
- CRDF $5.64
- Technical
- Relative Strength Index (RSI)
- UTMD 48.81
- CRDF 42.40
- Support Level
- UTMD $51.80
- CRDF $2.42
- Resistance Level
- UTMD $54.78
- CRDF $2.87
- Average True Range (ATR)
- UTMD 1.22
- CRDF 0.19
- MACD
- UTMD 0.35
- CRDF 0.01
- Stochastic Oscillator
- UTMD 66.48
- CRDF 27.91
About UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.